Document ID: chunk:federal_register_of_legislation:F2025C00036:clause:5_6a
Version: federal_register_of_legislation:F2025C00036
Segment Type: clause
Provision Reference: sch 5 cl 6A
Character Range: 511460–512316

6A        medicines (other than medicines that are used for gene therapy or that are medicinal cannabis products) that are:
          (a) compounded in a hospital by:
          (i) in the case of a private hospital—a hospital pharmacist who is engaged in the manufacture of therapeutic goods (other than biologicals) on the premises of the private hospital; or
          (ii) in the case of a public hospital—a pharmacist who is employed by the public hospital and is engaged in the manufacture of therapeutic goods (other than biologicals); and
          (b) compounded in anticipation of being needed for therapeutic application to patients of the hospital; and
          (c) considered by the hospital's drug and therapeutic committee (however called) to be appropriate for compounding in anticipation of being needed to treat a patient at the hospital